Strategic Blueprint, LLC Cybin Inc. Transaction History

Strategic Blueprint, LLC

  • $1.49 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024
SELL
$0.26 - $0.46 $1,560 - $2,760
-6,000 Reduced 15.79%
32,000 $8,000
Q1 2024

Apr 23, 2024
BUY
$0.3 - $0.46 $1,800 - $2,760
6,000 Added 18.75%
38,000 $15,000
Q2 2022

Aug 12, 2022
BUY
$0.41 - $0.88 $4,920 - $10,560
12,000 Added 60.0%
32,000 $18,000
Q4 2021

Feb 14, 2022
BUY
$1.13 - $2.31 $22,599 - $46,200
20,000 New
20,000 $24,000

Others Institutions Holding CYBN

# of Institutions
11
Shares Held
185K
Call Options Held
0
Put Options Held
0
View Full List

About CYBIN INC.

CYBN Quotes by TradingView
  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $2.07B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Strategic Blueprint, LLC Portfolio

Follow Strategic Blueprint, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email